All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
The move comes as the company faces ‘several challenges’ around the launching of medicines and timed out patents ...
While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization of $216.74 billion, has been making significant strides in the pharmaceutical industry, particularly ...
Hosted on MSN22h
Astrazeneca (AZN) Rises As Market Takes a Dip: Key FactsAstrazeneca (AZN) closed the latest trading day at $70.25, indicating a +0.95% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.47%. Meanwhile, the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback